Adverse effects of endometriosis on pregnancy: a case-control study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
22 Oct 2019
Historique:
received: 21 06 2019
accepted: 16 09 2019
entrez: 24 10 2019
pubmed: 24 10 2019
medline: 13 3 2020
Statut: epublish

Résumé

Endometriosis is a common disease occurring in 1-2% of all women of reproductive age. Although there is increasing evidence on the association between endometriosis and adverse perinatal outcomes, little is known about the effect of pre-pregnancy treatments for endometriosis on subsequent perinatal outcomes. Thus, this study aimed to evaluate maternal and neonatal outcomes in pregnant women with endometriosis and to investigate whether pre-pregnancy surgical treatment would affect these outcomes. This case-control study included 2769 patients who gave birth at Nagoya University Hospital located in Japan between 2010 and 2017. Maternal and neonatal outcomes were compared between the endometriosis group (n = 80) and the control group (n = 2689). The endometriosis group was further divided into two groups: patients with a history of surgical treatment such as cystectomy for ovarian endometriosis, ablation or excision of endometriotic implants, or adhesiolysis (surgical treatment group, n = 49) and those treated with only medications or without any treatment (non-surgical treatment group, n = 31). In the univariate analysis, placenta previa and postpartum hemorrhage were significantly increased in the endometriosis group compared to the control group (12.5% vs. 4.1%, p <  0.01 and 27.5% vs. 18.2%, p = 0.04, respectively). In the multivariate analysis, endometriosis significantly increased the odds ratio (OR) for placenta previa (adjusted OR, 3.19; 95% confidence interval [CI], 1.56-6.50, p <  0.01) but not for postpartum hemorrhage (adjusted OR, 1.14; 95% CI, 0.66-1.98, p = 0.64). Other maternal and neonatal outcomes were similar between the two groups. In patients with endometriosis, patients in the surgical treatment group were significantly associated with an increased risk of placenta previa (OR. 4.62; 95% CI, 2.11-10.10, p <  0.01); however, patients in the non-surgical treatment group were not associated with a high risk (OR, 1.63; 95% CI, 0.19-6.59, p = 0.36). Additionally, other maternal and neonatal outcomes were similar between the two groups. Women who have had surgical treatment for their endometriosis appear to have a higher risk for placenta previa. This may be due to the more severe stage of endometriosis often found in these patients. However, clinicians should be alert to this potential increased risk and manage these patients accordingly.

Sections du résumé

BACKGROUND BACKGROUND
Endometriosis is a common disease occurring in 1-2% of all women of reproductive age. Although there is increasing evidence on the association between endometriosis and adverse perinatal outcomes, little is known about the effect of pre-pregnancy treatments for endometriosis on subsequent perinatal outcomes. Thus, this study aimed to evaluate maternal and neonatal outcomes in pregnant women with endometriosis and to investigate whether pre-pregnancy surgical treatment would affect these outcomes.
METHODS METHODS
This case-control study included 2769 patients who gave birth at Nagoya University Hospital located in Japan between 2010 and 2017. Maternal and neonatal outcomes were compared between the endometriosis group (n = 80) and the control group (n = 2689). The endometriosis group was further divided into two groups: patients with a history of surgical treatment such as cystectomy for ovarian endometriosis, ablation or excision of endometriotic implants, or adhesiolysis (surgical treatment group, n = 49) and those treated with only medications or without any treatment (non-surgical treatment group, n = 31).
RESULTS RESULTS
In the univariate analysis, placenta previa and postpartum hemorrhage were significantly increased in the endometriosis group compared to the control group (12.5% vs. 4.1%, p <  0.01 and 27.5% vs. 18.2%, p = 0.04, respectively). In the multivariate analysis, endometriosis significantly increased the odds ratio (OR) for placenta previa (adjusted OR, 3.19; 95% confidence interval [CI], 1.56-6.50, p <  0.01) but not for postpartum hemorrhage (adjusted OR, 1.14; 95% CI, 0.66-1.98, p = 0.64). Other maternal and neonatal outcomes were similar between the two groups. In patients with endometriosis, patients in the surgical treatment group were significantly associated with an increased risk of placenta previa (OR. 4.62; 95% CI, 2.11-10.10, p <  0.01); however, patients in the non-surgical treatment group were not associated with a high risk (OR, 1.63; 95% CI, 0.19-6.59, p = 0.36). Additionally, other maternal and neonatal outcomes were similar between the two groups.
CONCLUSION CONCLUSIONS
Women who have had surgical treatment for their endometriosis appear to have a higher risk for placenta previa. This may be due to the more severe stage of endometriosis often found in these patients. However, clinicians should be alert to this potential increased risk and manage these patients accordingly.

Identifiants

pubmed: 31640604
doi: 10.1186/s12884-019-2514-1
pii: 10.1186/s12884-019-2514-1
pmc: PMC6805464
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

373

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 19K18637
Organisme : Japan Society for the Promotion of Science
ID : 15H02660

Références

Hum Reprod. 2005 Oct;20(10):2698-704
pubmed: 15980014
J Matern Fetal Neonatal Med. 2015;28(15):1795-8
pubmed: 25262994
J Obstet Gynaecol Res. 2017 Oct;43(10):1517-1521
pubmed: 28737252
Hum Reprod Update. 2009 Jul-Aug;15(4):441-61
pubmed: 19279046
Hum Reprod. 2009 Dec;24(12):3096-107
pubmed: 19684046
Biomed Res Int. 2016;2016:3260952
pubmed: 27148550
BJOG. 2018 Jan;125(1):55-62
pubmed: 28444957
Eur Radiol. 2007 Jul;17(7):1813-9
pubmed: 17119973
Hum Reprod Update. 2016 Jan-Feb;22(1):70-103
pubmed: 26450609
Fertil Steril. 2016 Jul;106(1):164-171.e1
pubmed: 27060727
Fertil Steril. 2017 Oct;108(4):667-672.e5
pubmed: 28874260
Chin Med J (Engl). 2015 Feb 20;128(4):455-8
pubmed: 25673445
Arch Gynecol Obstet. 2017 Jan;295(1):141-151
pubmed: 27770245
Fertil Steril. 2018 Aug;110(3):459-466
pubmed: 30098698
Hum Reprod. 2018 Oct 1;33(10):1854-1865
pubmed: 30239732
Fertil Steril. 2017 Dec;108(6):895-912
pubmed: 29202964
Nat Rev Endocrinol. 2014 May;10(5):261-75
pubmed: 24366116
Clin Obstet Gynecol. 2017 Sep;60(3):477-484
pubmed: 28742580
Am J Obstet Gynecol. 1999 Mar;180(3 Pt 1):519-23
pubmed: 10076121
BJOG. 2012 Nov;119(12):1538-43
pubmed: 22900995
Reprod Biomed Online. 2019 Jun;38(6):917-925
pubmed: 30928300
PLoS One. 2016 Dec 22;11(12):e0168476
pubmed: 28005934
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Acta Obstet Gynecol Scand. 2017 Jun;96(6):623-632
pubmed: 28423456
Curr Obstet Gynecol Rep. 2017 Mar;6(1):34-41
pubmed: 29276652
Fertil Steril. 2012 Jul;98(1):36-40
pubmed: 22658345
Reprod Biol Endocrinol. 2016 Nov 3;14(1):73
pubmed: 27809920
J Matern Fetal Neonatal Med. 2019 Mar;32(5):845-850
pubmed: 29037097
Acta Obstet Gynecol Scand. 2017 Jun;96(6):751-760
pubmed: 28181672
Hum Reprod. 2014 Mar;29(3):400-12
pubmed: 24435778
Pediatr Int. 2014 Oct;56(5):702-8
pubmed: 24617834
Masui. 2010 Mar;59(3):347-56
pubmed: 20229753
Acta Obstet Gynecol Scand. 2018 Sep;97(9):1073-1090
pubmed: 29753309

Auteurs

Mayo Miura (M)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Takafumi Ushida (T)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Kenji Imai (K)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Jingwen Wang (J)

Laboratory of Bell Research Center-Department of Obstetrics and Gynecology collaborative research, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Yoshinori Moriyama (Y)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Tomoko Nakano-Kobayashi (T)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Satoko Osuka (S)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Center for Maternal-Neonatal Care, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8560, Japan.

Fumitaka Kikkawa (F)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Tomomi Kotani (T)

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. itoto@med.nagoya-u.ac.jp.
Center for Maternal-Neonatal Care, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8560, Japan. itoto@med.nagoya-u.ac.jp.
Department of Maternal and Perinatal Medicine, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8560, Japan. itoto@med.nagoya-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH